Articles

This cinema-related stock is up 77% this year amid box-office rebound. It’s not AMC or Cinemark.

In 2025 “we will finally see what could be the new normal,” as the box office continues its rebound, according to National CineMedia CEO Tom Lesinski.

United Natural Foods’ stock soars 23% as health-food supplier delivers a surprise adjusted profit

United Natural Foods Inc.’s stock soared 23% Tuesday after the health-food supplier delivered a surprise adjusted profit for its fiscal first quarter and sales that easily beat estimates.

She paid off $300,000 in debt as a first-generation American. ‘Hard work’ wasn’t the answer.

Bernadette Joy’s pursuit of the American dream left her drowning in student loans, car payments and mortgage debt. In a new book, she explains how she paid down a six-figure debt in three years.

C3.ai is still ‘extremely unprofitable’ so don’t buy the stock, analyst says

C3’s stock bounced back, but J.P. Morgan has a price target that implies a 35% downside.

Walgreens’ stock rockets higher on report of talks to sell itself to private equity

Shares of Walgreens Boots Alliance Inc. were up sharply on Tuesday after the Wall Street Journal reported that the drugstore chain was in discussions to sell itself to private-equity firm Sycamore Partners.

Traders are pretty sure of a Fed rate cut. What happens if inflation data is too hot?

Traders are pretty confident the Fed will deliver a rate cut next week. What happens if inflation data throws the market a curveball.

The Social Security Fairness Act is a bad idea

This legislation would allow some workers to double-dip and speeds the exhaustion of the trust fund

Investor optimism for U.S. stocks eclipsing 2000’s dot-com bubble raises ‘negative’ shock risk

“U.S. consumers have never felt so optimistic about gains in the stock market over the next 12 months,” according to Deutsche Bank Research.

Forget ‘Dogs of the Dow.’ Here is a better strategy for picking dividend stocks.

Look beyond the dividends

ServiceTitan IPO raises price on deal demand and appetite for new issuers

In a big move, ServiceTitan boosts is estimate price range to $65-$67 a share from $52-$57.

CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease

CervoMed Inc.’s stock cratered early Tuesday after the biotech company said a midstage trial of a treatment for patients with dementia with Lewy bodies, or DLB, failed to meet its main goals.

Olaf Scholz calls for ‘support’ for German EV makers at visit to Ford factory in Cologne

German chancellor Olaf Scholz called for subsidies for battery makers to protect jobs and drive the transition towards “electromobility”
1 691 692 693 694 695 2,455